World Health Organization. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017.
Google Scholar
Belyhun Y, Maier M, Mulu A, Diro E, Liebert UG. Hepatitis viruses in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2016. https://doi.org/10.1186/s12879-016-2090-1.
Article
PubMed
PubMed Central
Google Scholar
Kebede KM, Abateneh DD, Belay AS. Hepatitis B virus infection among pregnant women in Ethiopia: a systematic review and meta-analysis of prevalence studies. BMC Infect Dis. 2018. https://doi.org/10.1186/s12879-018-3234-2.
Article
PubMed
PubMed Central
Google Scholar
Edmunds WJ, Medley GF, Nokes DJ, et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect. 1996;117:313–25.
Article
PubMed
PubMed Central
CAS
Google Scholar
Tegegne D, Desta K, Tegbaru B, Tilahun T. Seroprevalence and transmission of hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa, Ethiopia: a cross sectional study. BMC Res Notes. 2014;7(1):239.
Article
PubMed
PubMed Central
Google Scholar
World Health Organization. Hepatitis B vaccines-WHO position paper. Wkly Epidemiol Rec. 2009;84(40):405–20.
Google Scholar
Cui F, Li L, Hadler SC, et al. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992–2005. Vaccine. 2010;28(37):5973–8.
Article
PubMed
Google Scholar
Federal Democratic Republic of Ethiopia Ministry of Health. Health Sector Transformation Plan (HSTP) (2015/2016–2019/2020). Addis Ababa: Federal Ministry of Health; 2015.
Google Scholar
Shimakawa Y, Lemoine M, Njai HF, et al. Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia. Gut. 2016. https://doi.org/10.1136/gutjnl-2015-309892.
Article
PubMed
Google Scholar
World Health Organization. SDG 3: ensure healthy lives and promote wellbeing for all at all ages. 2019. https://www.who.int/sdg/targets/en/. Accessed 14 May 2019.
Federal Democratic Republic of Ethiopia. National guideline for prevention and control of viral hepatitis in Ethiopia. Addis Ababa: Federal Ministry of Health; 2016.
Google Scholar
Klingler C, Thoumi AI, Mrthinjayam VS. Cost-effectiveness analysis of an additional birth dose of hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique. Vaccine. 2012;31:252–9.
Article
PubMed
Google Scholar
Fattovich G. Natural history of hepatitis B. J Hepatol. 2003;39(Suppl 1):50–8.
Article
Google Scholar
Ethiopian Public Health Institute [Ethiopia] and ICF. Ethiopia Mini-Demographic and Health Survey 2019: Key Indicators. Rockville: EPHI and ICF; 2019.
Google Scholar
Margolis HS, Coleman PJ, Brown RE, et al. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA. 1995;20(4):992–1000.
Google Scholar
de Franchis R, Hadengue A, Lau G, et al. EASL international consensus conference on hepatitis B, 13–14 September, 2002, Geneva, Switzerland Consensus statement (long version). J Hepatol. 2003;39(Suppl 1):3–25.
Google Scholar
World Health Organization. Global Health Observatory, Life tables. 2019. http://apps.who.int/gho/athena/data/GHO/LIFE. Accessed 8 Jan 2019.
World Health Organization. Cost-effectiveness and Strategic Planning (WHO-CHOICE): Health State Valuation. 2018. http://www.who.int/choice/demography/health_valuations/en/. Accessed 22 May 2018.
Ribeiro RM, Lo A, Perelson AS, et al. Dynamics of hepatitis B virus infection. Microbes Infect. 2002;4:829–35.
Article
PubMed
CAS
Google Scholar
Desalegn H, Abera H, Berhe N, et al. Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia. BMC Med. 2018. https://doi.org/10.1186/s12916-018-1229-x.
Article
PubMed
PubMed Central
Google Scholar
Bortolotti F, Guido M, Bartolacci S, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology. 2006;43:556–62.
Article
PubMed
Google Scholar
Bortolotti F, Jara P, Crivellaro C, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol. 1998;29:184–90.
Article
PubMed
CAS
Google Scholar
Kim SY, Salomon JA, Goldie SJ. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves. Bull World Health Organ. 2007;85(11):833–42.
Article
PubMed
PubMed Central
Google Scholar
Fan L, Owusu-Edudei K Jr, Schillie SF, Murphy TV. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection. Hepatology. 2016;63(5):1471–80.
Article
PubMed
Google Scholar
Tan-Torres Edejer T, Baltussen R, Adam T, et al. Making choices in health WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003.
Google Scholar
Institute of Health Metrics and Evaluation (IHME). Global Burden of Disease 2017: Disability weights. 2018. http://ghdx.healthdata.org/record/ihme-data/gbd-2017-disability-weights. Accessed 8 Nov 2018.
Lee C, Gong Y, Brok J, et al. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006;2:004790.
Google Scholar
World Health Organization. Guidelines for estimating costs of introducing new vaccines into the national immunization system. Geneva: World Health Organization; 2002.
Google Scholar
UNICEF. Supplies and logistics. Vaccine price Data. HepB. 2019. https://www.unicef.org/supply/files/2018_03_01_HepB.pdf. Accessed 19 Feb 2019.
UNICEF. 2019. Supplies and logistics. Auto-Disable (AD) and Re-Use Prevention (RUP) Syringes and Safety Boxes—current price data.
US inflation Calculator. 2019. https://www.usinflationcalculator.com/. Accessed 19 Feb 2019.
Management Science for Health (MSH). International Drug Price Indicator Guide. 2015 Edition. 2016. http://www.msh.org/blog/2014/07/30/2013-international-drug-price-indicator-guide-now-available. Accessed 1 Feb 2018.
World Health Organization. Health Services Delivery Costs. 2018. http://www.who.int/choice/cost-effectiveness/inputs/health_service/en/. Accessed 20 Feb 2019.
Nayagam S, Conteh L, Sicuri E, et al. Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modeling analysis. Lancet Glob Health. 2016;4:e568–78.
Article
PubMed
Google Scholar
Briggs A. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value Health. 2005;8:1–2.
Article
PubMed
Google Scholar
World Bank. GDP per capita (Current US$) 2019. 2019. https://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 19 July 2019.
Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. BMJ Glob Health. 2018. https://doi.org/10.1136/bmjgh-2018-000964.
Article
PubMed
PubMed Central
Google Scholar
The Government of Federal Democratic Republic of Ethiopia. 2017. Proposal for Support Submitted to the Global Alliance for Vaccines and Immunization (GAVI) and The Vaccine Fund. Addis Ababa, Ethiopia: Federal Ministry of Health. Woods B, Revill P, Sculpher M, et al. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research. Value Health. 2016;https://doi.org/10.1016/j.jval.2016.02.017.
Laxminarayan R, Mills AJ, Breman JG, et al. Advancement of global health: key messages from the disease control priorities project. Lancet. 2006;367(9517):1193–208.
Article
PubMed
Google Scholar
Memirie ST, Tolla MT, Desalegn D, et al. A cost-effectiveness analysis of maternal and neonatal health interventions in Ethiopia. Health Policy Plann. 2019. https://doi.org/10.1093/heapol/czz034.
Article
Google Scholar
Tolla MT, Norheim OF, Memirie ST, et al. Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis. Cost Eff Resour Alloc. 2016;14:10.
Article
PubMed
PubMed Central
Google Scholar
Griffiths UK, Hutton G, Pascoal EDD. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique. Health Policy Plann. 2005;20(1):50–9.
Article
Google Scholar
Hill A, Gotham D, Cooke G, et al. Analysis of minimum target prices for production of entecavir to treat hepatitis B in high-and low-income countries. J Virus Erad. 2015;1:103–10.
PubMed
PubMed Central
Google Scholar
Ruggeri M, Basile M, Coretti S, et al. Economic analysis and budget impact of tenofovir and entecavir in the first-line treatment of hepatitis B virus in Italy. Appl Health Econ Health Policy. 2017;15:479–90.
Article
PubMed
CAS
Google Scholar
World Health Organization. In-depth evaluation of the reaching every district approach in the African region. Reaching every district approach in the African region valuation report, 2007.
Mann C, Dessie E, Adugna M, and Berman P. 2016. Measuring efficiency of public health centers in Ethiopia. Harvard T.H. Chan School of Public Health and Federal Democratic Republic of Ethiopia Ministry of Health. Boston, Massachusetts and Addis Ababa, Ethiopia.
Mann C, Dessie E, Adugna M, Berman P. 2016. Measuring efficiency of public primary hospitals in Ethiopia. Harvard T.H. Chan School of Public Health and Federal Democratic Republic of Ethiopia Ministry of Health. Boston, Massachusetts and Addis Ababa, Ethiopia.
Chang AY, Riumallo-Herl C, Perales NA, et al. The equity impact vaccines may have on averting deaths and medical impoverishment in developing countries. Health Aff. 2018;37(2):316–24.
Article
Google Scholar
Federal Democratic Republic of Ethiopia Ministry of Health. Ethiopia Health Accounts 2016/2017. Addis Ababa: Ministry of Health; 2019.
Google Scholar
Admasu K, Tamire A, Tsegaye S. Envisioning the future of the health sector: an update. Federal Democratic Republic of Ethiopia Ministry of Health Quarterly Health Bulletin. 2014;6:3–12.
Google Scholar